Characteristics of chemotherapy-induced diabetes mellitus in acute lymphoblastic leukemia patients / 浙江大学学报(英文版)(B辑:生物医学和生物技术)
Journal of Zhejiang University. Science. B
;
(12): 740-744, 2020.
Artículo
en Inglés
| WPRIM
| ID: wpr-1010552
ABSTRACT
Acute lymphocytic leukemia (ALL) is one of the most common malignancies, especially in young people. Combination chemotherapy for ALL typically includes corticosteroids (Kantarjian et al., 2000). Hyperglycemia is a well-recognized complication of corticosteroids, and chemotherapy-induced diabetes (CID) is not uncommon (27.5%-37.0%) during the treatment of ALL (Hsu et al., 2002; Weiser et al., 2004; Alves et al., 2007). Besides the effect of corticosteroids, potential factors triggering hyperglycemia in ALL also include direct infiltration of the pancreas by leukemia cells and β cell dysfunction induced by chemotherapeutic agents such as L-asparagine (Mohn et al., 2004).
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Asunto principal:
Factores de Edad
/
Diabetes Mellitus
/
Leucemia-Linfoma Linfoblástico de Células Precursoras
/
Antineoplásicos
Límite:
Adolescente
/
Adulto
/
Anciano
/
Femenino
/
Humanos
/
Masculino
Idioma:
Inglés
Revista:
Journal of Zhejiang University. Science. B
Año:
2020
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS